DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

The market is witnessing robust growth due to the increasing complexity of clinical trials, rising patient-centric approaches ...

Slope is the only end-to-end, vendor-agnostic platform for managing biospecimens and clinical inventory across the entire clinical research ecosystem. Trusted by 2,200+ sites in 23+ countries, Slope ...

From 28 April, IVDs used clinical trials will be subject to an upfront assessment by the MHRA as part of a Clinical Trial of ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand enrolment.

Clinical trials are conducted in several phases to determine whether new treatments are safe and effective. The results from Phases 1, 2 and 3 inform the U.S. Food and Drug Administration (FDA) on ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

In a new draft guidance issued on January 14, 2026, the FDA discussed the use of a modern statistical methodology in clinical trials designed to ...

When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...